Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MapTrek, an Interactive, m-Health Intervention to Increase Activity Among Patients at Risk for Type 2 Diabetes

NCT03193229 is registered in ClinicalTrials.gov with Philip Polgreen as lead sponsor.

NCT NCT03193229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03193229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MapTrek, an Interactive, m-Health Intervention to Increase Activity Among Patients at Risk for Type 2 Diabetes
Lead sponsor
Philip Polgreen
Phase
Not applicable
Overall status
Completed
Start date
May 15, 2017
Completion date
May 4, 2018
Enrollment
430 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, pre diabetes